title: Sacubitril/Valsartan (Entresto) for Heart Failure.
authors.affiliation: Massachusetts College of Pharmacy and Health Sciences University and Brigham and Women's Hospital, Boston, MA, USA.
authors.forename: Judy
authors.initials: J
authors.lastname: Cheng
mesh_terms: D000613:Aminobutyrates / Q000008:administration & dosage / Q000009:adverse effects; D047228:Angiotensin II Type 1 Receptor Blockers / Q000008:administration & dosage / Q000009:adverse effects; D057911:Angiotensin Receptor Antagonists / Q000008:administration & dosage / Q000009:adverse effects; D001713:Biphenyl Compounds; D002908:Chronic Disease; D004338:Drug Combinations; D006333:Heart Failure / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced / Q000517:prevention & control; D007022:Hypotension / Q000139:chemically induced / Q000517:prevention & control; D015260:Neprilysin / Q000037:antagonists & inhibitors; D051437:Renal Insufficiency / Q000139:chemically induced / Q000517:prevention & control; D012720:Severity of Illness Index; D013318:Stroke Volume / Q000187:drug effects; D013777:Tetrazoles / Q000008:administration & dosage / Q000009:adverse effects; D016896:Treatment Outcome; D000068756:Valsartan / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D000613:Aminobutyrates; D047228:Angiotensin II Type 1 Receptor Blockers; D057911:Angiotensin Receptor Antagonists; D001713:Biphenyl Compounds; D004338:Drug Combinations; D013777:Tetrazoles; D000068756:Valsartan; D015260:Neprilysin; C549068:sacubitril and valsartan sodium hydrate drug combination